Friday 23rd August 2002 |
Text too small? |
AMP has a heavy exposure to the British sharemarket, where insurers have suffered from heavy falls. That exposure was the biggest factor in a $A6 million loss from investment activities.
The result was in line with analysts' expectations following two consecutive profit warnings. Since March AMP's share price has fallen 26% to $A14.
AMP's "core recurring operating margins" rose 3% to $A470 million but the company said markets would remain "difficult."
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b